Related Experiment Video
Updated: Feb 10, 2026
06:52
Reconstruct Human Retinoblastoma In Vitro
Published on: October 11, 2022
1.8K
Retinoblastoma for Pediatric Ophthalmologists
Alaa AlAli1, Stephanie Kletke1, Brenda Gallie1,2,3,4
1Department of Ophthalmology & Vision Sciences, University of Toronto, Toronto, Canada.
Summary
Retinoblastoma, the most common childhood eye cancer, arises from RB1 gene mutations. Early diagnosis and specialized care significantly improve survival rates, exceeding 95% for localized disease.
Area of Science:
- Pediatric Oncology
- Ophthalmology
- Genetics
Background:
- Retinoblastoma is the most frequent intraocular malignancy in children.
- It originates from biallelic RB1 tumor suppressor gene mutations, causing retinal cell transformation.
- Common presentations include leukocoria (white pupil) and strabismus.
Purpose of the Study:
- To provide a comprehensive overview of retinoblastoma.
- To cover epidemiology, genetics, screening, diagnosis, classification, and current treatments.
- To highlight the importance of staging and multidisciplinary care.
Main Methods:
- Review of epidemiological data.
- Analysis of genetic underpinnings (RB1 gene).
- Summary of diagnostic and staging criteria (AJCC TNMH system).
- Overview of current therapeutic modalities.
Main Results:
- Heritable retinoblastoma constitutes 45% of cases, with 80% being bilateral.
- Prognosis is strongly linked to disease stage at presentation.
- Survival rates exceed 95% with early diagnosis and specialized treatment.
- Survival drops below 50% with extraocular spread.
Conclusions:
- Retinoblastoma management requires a multidisciplinary approach.
- The AJCC TNMH staging system is crucial for prognosis.
- Timely diagnosis and treatment in specialized centers are vital for optimal outcomes.
Related Concept Videos
01:20The Retinoblastoma Gene
4.8K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.8K
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
274
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
274
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
330
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
330
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
245
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
245
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
307
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
307
01:23Negative Regulator Molecules
38.6K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.6K